Blood Pressure Meds Recalled, Possibly Linked To Cancer Concerns

January 3, 2019 By Justin Gould Health, News 0

WASHINGTON – Medicine for your heart is getting pulled off of shelves because of cancer concerns.

The drug maker Aurobindo is pulling eighty lots of the blood pressure medicine Valsartan.

They said it might contain small amounts of a chemical linked to cancer.











A full list of the recalled products is posted on the FDA’s website.

Products can be identified by checking the product name, manufacturer details, and batch or lot number on the pill bottles.

Expiration dates range from May 2019 to March 2021.









The FDA explained that users should not just stop taking it because that could lead to greater risk.

Experts said to go to your doctor first to get an alternative substitute.

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.